Montelukast in Acute Bronchiolitis
Not Applicable
Withdrawn
- Conditions
- Bronchiolitis
- Registration Number
- SLCTR/2015/003
- Lead Sponsor
- Department of Paediatrics
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Withdrawn
- Sex
- Not specified
- Target Recruitment
- 92
Inclusion Criteria
1. Children between 3 months and 18 months with clinical features which are considered in making a diagnosis of bronchiolitis such as prodromal fever, rhinorrhoea and cough
2. At least 2 of the following signs on admission: chest retractions, tachypnoea, wheezing
Exclusion Criteria
1. Symptoms lasting for more than 5 days before admission
2. Previous history of wheezing
3. Underlying chronic diseases eg. cardiac disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The length of stay in days from admission to discharge. Fitness to discharge will be assessed by Wang clinical severity score, need for nebulization and feeding. [Twice daily until discharge and at the end of 7 days of treatment]<br>
- Secondary Outcome Measures
Name Time Method Wang clinical severity score evolution <br> [Twice daily until discharge and at the end of 7 days of treatment]<br>Oxygen saturation [Twice daily until discharge and at the end of 7 days of treatment]<br>Pulse rate [Twice daily until discharge and at the end of 7 days of treatment ]<br>Need for ICU care [Twice daily until discharge and at the end of 7 days of treatment ]<br>Need for add on therapy [Twice daily until discharge and at the end of 7 days of treatment ]<br>Readmission rate over the 7 days following discharge [Twice daily until discharge and at the end of 7 days of treatment ]<br>